Elranatamab vs Moxifloxacin

## Elranatamab vs Moxifloxacin: Overview

This comparison examines the pharmacological differences between **Elranatamab** and **Moxifloxacin**.

## Mechanism of Action

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

## Pharmacokinetics

**Half-life**: Elranatamab — N/A; Moxifloxacin — 12 hours.

## Chemical Properties

**Molecular Formula**: Elranatamab — N/A; Moxifloxacin — C21H24FN3O4.

**Molecular Weight**: Elranatamab — N/A; Moxifloxacin — 401.4350 g/mol.

**Type**: Elranatamab — Antibody; Moxifloxacin — Small molecule.